GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, F3, FABP3, FABP4, FLT3, KDR, KIT, MET, SRC, TERT, XDH |
7.11961 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1B1, FABP4, KDR, KIT, MMP9, SRC, TERT |
6.9913 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DNMT1, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, SRC, TERT |
6.66785 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
6.63252 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
6.35458 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DNMT1, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, SRC |
6.10886 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.98237 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.98237 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.96556 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CYP1B1, DNMT1, F3, FABP3, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, SRC, TERT, XDH |
5.96556 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT, XDH |
5.96556 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, F3, FLT3, KDR, KIT, MET, MMP9, SRC, TERT, XDH |
5.96556 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, F3, FLT3, KDR, KIT, MET, MMP9, SRC, TERT, XDH |
5.96082 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT, XDH |
5.94522 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DNMT1, DRD1, FABP3, IGF1R, MMP2, MMP9, SRC |
5.94522 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, KIT |
5.94522 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, KIT |
5.94522 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, KDR, SRC |
5.94522 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, SRC, TERT |
5.93127 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CYP1B1, F3, FLT3, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT, XDH |
5.7879 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DYRK1A, F3, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, SRC, TERT, XDH |
5.62167 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.60318 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.47166 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, SRC |
5.47166 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DYRK1A, F3, FABP3, FLT3, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, SRC, TERT, XDH |
5.46165 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, FABP3, KDR, SRC |
5.41641 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CYP1B1, F3, FLT3, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT, XDH |
5.41641 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.41641 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
5.2952 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.29372 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2 |
5.27547 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
5.27547 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
5.16282 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9 |
5.05123 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, DNMT1, DRD1, FABP3, FLT3, IGF1R, KIT, MMP2, SRC |
4.99725 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, FABP3, FABP4, FLT3, MET, SRC, TERT |
4.97312 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, KIT, MET |
4.80589 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT |
4.72787 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.70838 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, DNMT1, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, SRC, TERT |
4.63352 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.63352 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP3A4, FABP3, FUT7, PIM1, XDH |
4.45004 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CYP1B1, F3, FLT3, IGF1R, KDR, MMP9, PIM1, SRC, TERT, XDH |
4.43017 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
4.39745 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1B1 |
4.3795 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT |
4.33329 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DNMT1, DRD1, F3, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, SRC, TERT |
4.26751 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, F3, FABP3, FABP4, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, SRC, TERT, XDH |
4.25112 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, F3, FLT3, KDR, KIT, MET, SRC, XDH |
4.22584 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CYP1B1, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MET, MMP9, SRC, XDH |
4.1447 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, BACE1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, SRC, XDH |
4.1075 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, DYRK1A, F3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC, TERT, XDH |
4.09924 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1B1, DRD1, F3, FABP4, IGF1R, KIT, MET, MMP1, MMP2, MMP9, PIM1, SRC |
4.07314 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CNR1, CYP19A1, CYP1A1, CYP1B1, DRD1, DYRK1A, FABP4, FLT3, FUT7, KDR, KIT, MET, MMP2, MMP9, PIM1, SRC, TERT |
4.01239 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1 |
3.98393 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, SRC, TERT |
3.92566 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, KDR, SRC |
3.89418 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CNR1, CNR2, CYP19A1, DYRK1A, F3, FABP4, IGF1R, MET, MMP2, SRC, TERT, XDH |
3.89418 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, FABP3, FLT3, SRC |
3.85884 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, BCL2, CNR1, CYP1B1, F3, FABP4, FLT3, KDR, KIT, MET, MMP2, MMP9, SRC, TERT, XDH |
3.85884 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CNR1, CYP1A1, CYP1B1, DRD1, FLT3, SRC |
3.84053 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1B1, DNMT1, DRD1, DYRK1A, FABP3, FABP4, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT, XDH |
3.81757 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, FABP4, KIT, MMP9, TERT |
3.81403 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, F3, FLT3, KDR, KIT, MET, MMP9, SRC, TERT, XDH |
3.73522 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DNMT1, DRD1, FABP3, FLT3, IGF1R, MMP2, SRC |
3.66171 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CNR1, DRD1, KDR, SRC |
3.55714 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
3.53416 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, CNR1, DNMT1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC |
3.46231 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.46231 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
3.46231 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
3.40679 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, FLT3, KIT, MET, PIM1, SRC |
3.38817 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DNMT1, DRD1, FABP3, FLT3, IGF1R, MMP2, SRC |
3.38817 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, KIT, MMP2, SRC, TERT |
3.38817 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.36185 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, FABP3, FABP4, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP2, PIM1, SRC, TERT, XDH |
3.31219 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1B1, CYP3A4, FABP3, FABP4 |
3.25933 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, IGF1R, KDR, MMP9, PIM1, SRC, TERT |
3.24913 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.22854 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
3.22057 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, CNR1, CNR2, DRD1, KDR, SRC |
3.19372 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.16255 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, XDH |
3.16255 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, F3, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, TERT |
3.14 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, APP, AURKB, BCL2, CNR1, CNR2, CYP1B1, DRD1, F3, FABP4, FLT3, IGF1R, KIT, MET, MMP9, PIM1, SRC, TERT, XDH |
3.13913 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
3.12173 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3 |
3.09035 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
3.05215 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
3.05215 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
3.05215 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CNR1, CYP1B1, F3, KDR, KIT, MET, MMP9, PIM1, SRC, TERT |
3.05215 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, BCL2, CNR1, CNR2, DRD1, F3, FABP4, FLT3, IGF1R, KIT, MMP9, SRC, TERT, XDH |
2.98917 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1B1, DNMT1, DRD1, DYRK1A, FABP3, FABP4, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT, XDH |
2.9752 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, XDH |
2.9614 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DNMT1, DRD1, IGF1R, MMP2, MMP9, SRC |
2.9614 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, DRD1, FABP3, FABP4, MET |
2.92314 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CNR1, CYP19A1, CYP1A1, DRD1, KIT, MMP2, MMP9, SRC |
2.91998 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, BCL2, CA2, CA7, CNR1, DRD1, MMP9 |
2.85477 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD1, SRC, TERT |
2.85477 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CYP1A1, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, KIT, MET |
2.85477 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F3, KIT, MET, SRC, XDH |
2.85477 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1 |
2.85477 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CYP1B1, FABP4, IGF1R, MET, MMP9, PIM1, SRC |
2.85477 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.74761 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.71547 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, SRC, TERT |
2.71547 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, FLT3, SRC |
2.65731 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1 |
2.65334 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, FUT7, KDR, KIT, MET, MMP1, MMP9, SRC |
2.64582 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, FUT7, KDR, KIT, MMP1, MMP9, SRC |
2.63225 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, FABP3, FLT3, KIT, SRC |
2.62821 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.62346 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, KIT, SRC |
2.60051 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.60051 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
2.59197 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
2.58401 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CNR1, CNR2, CYP19A1, DRD1, DYRK1A, IGF1R, MET, MMP9, SRC, TERT, XDH |
2.58401 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AXL, BCL2, CA2, CNR1, CYP1B1, F3, KDR, KIT, PIM1, SRC, TERT |
2.58266 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DNMT1, DRD1, FLT3, IGF1R, KIT, MMP2, SRC |
2.54797 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, CNR2, DRD1, DYRK1A, IGF1R, MET, MMP9, SRC, TERT, XDH |
2.51998 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, CNR2, DRD1, DYRK1A, IGF1R, MET, MMP9, SRC, TERT, XDH |
2.51107 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.51107 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, BCL2, DNMT1, DRD1, DYRK1A, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, SRC, XDH |
2.4756 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F3, KIT, MET, SRC |
2.47023 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, SRC, TERT |
2.45282 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, MMP9 |
2.43761 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.43761 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, F3, FABP3, FABP4, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, SRC, TERT, XDH |
2.43527 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, DRD1, FABP3, FLT3, KDR, KIT, MMP9, SRC, XDH |
2.43527 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, DRD1, FABP3, FLT3, KDR, KIT, MMP9, SRC, XDH |
2.43527 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3 |
2.43303 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.43101 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, BACE1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, XDH |
2.43101 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, IGF1R, MMP2, SRC |
2.43046 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CNR1, CYP1A1, DRD1, KIT, SRC |
2.41527 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, SRC, TERT |
2.41085 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.40793 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.40022 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CYP19A1, CYP1A1, CYP1B1, DRD1, DYRK1A, FLT3, KDR, KIT, MMP9, PIM1, SRC |
2.39864 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, FUT7, KDR, KIT, MMP1, MMP9, SRC |
2.38734 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, BCL2, CYP1A1, DRD1, FABP4, FLT3, FUT7, KDR, KIT, MET, MMP2, MMP9, SRC, TERT |
2.37669 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, DYRK1A, SRC |
2.35226 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7 |
2.34897 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, SRC |
2.34169 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1B1, DRD1, KIT, MMP2, MMP9, SRC, TERT |
2.32544 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, MMP9, SRC, TERT |
2.31076 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, SRC |
2.31049 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, BCL2, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, SRC, XDH |
2.2946 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC |
2.29215 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, TERT |
2.25601 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, IGF1R, MMP2, SRC |
2.25601 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AURKB, AXL, BACE1, BCL2, CYP1A1, CYP3A4, DRD1, DYRK1A, F3, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, SRC, XDH |
2.25306 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, SRC, TERT |
2.24868 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.23986 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.23986 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, SRC |
2.2213 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, BCL2, DNMT1, DRD1, DYRK1A, F3, FABP3, FLT3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT, XDH |
2.19665 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, F3, FABP4, KDR, MET |
2.19665 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC |
2.19568 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, DYRK1A, SRC |
2.18063 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, BCL2, DNMT1, DYRK1A, FLT3, KDR, KIT, MMP9, SRC, XDH |
2.15703 |
[BP] GO:0030098 |
lymphocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT |
2.14549 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP2, MMP9 |
2.14549 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP2, MMP9 |
2.13985 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CYP1B1, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT, XDH |
2.13732 |
[BP] GO:0014911 |
positive regulation of smooth muscle cell migration
|
BCL2, SRC, TERT |
2.10351 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.10351 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2 |
2.10351 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.10351 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.09953 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, FABP3, KDR, MMP2, SRC |
2.05795 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, SRC, XDH |
2.03717 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, APP, AURKB, BCL2, F3, FLT3, KIT, MET, MMP9, SRC, TERT, XDH |
2.02134 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.01396 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, BCL2, CA2, CNR1, CYP1B1, F3, KDR, KIT, MET, MMP9, PIM1, SRC, TERT, XDH |
2.01012 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, SRC, XDH |
2.00964 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, BCL2, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, SRC, XDH |
2.00634 |
[BP] GO:1901342 |
regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, TERT, XDH |
2.00634 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, DRD1, F3, FLT3, IGF1R, KDR, KIT, MET, MMP2, PIM1, SRC, TERT |
4.09915 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, APP, AXL, BACE1, CA2, CA4, CA9, CNR1, CNR2, DRD1, F3, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.32618 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, BACE1, CA4, CNR1, CNR2, DRD1, F3, FLT3, IGF1R, KDR, MET |
3.22057 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, F3, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP2, PIM1, SRC, TERT |
3.12796 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, APP, AXL, BACE1, CA4, F3, MET |
2.43761 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, F3, FLT3, FUT7, IGF1R, KDR, KIT, MET, SRC |
2.32184 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, BACE1, CNR1, CNR2, DRD1, FLT3, IGF1R, KDR, MET |
2.2386 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
7.97832 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BACE1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DNMT1, DYRK1A, F3, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, SRC, TERT, XDH |
7.43717 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DNMT1, MMP1, MMP2, MMP9, PIM1, XDH |
6.63252 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, ALPL, APP, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, F3, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, SRC, TERT, XDH |
6.60047 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.64276 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
5.41641 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
5.37587 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
5.15127 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.05123 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.94344 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
4.14444 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
3.96633 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1B1, CYP3A4, XDH |
3.38817 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
3.38817 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DNMT1, DRD1, KIT, MMP1, MMP2, MMP9, PIM1, TERT, XDH |
3.29813 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
3.15756 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
3.12796 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.84018 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1B1, CYP3A4, SRC |
2.74761 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TERT |
2.68789 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1B1, CYP3A4, SRC |
2.62346 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.62346 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.62346 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, F3, FLT3, IGF1R, KDR, KIT, MET |
2.60257 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, F3, FLT3, IGF1R, KDR, KIT, MET |
2.60257 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.57786 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DNMT1, KIT, MMP1, MMP2, MMP9, PIM1, TERT, XDH |
2.46616 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, F3, FLT3, IGF1R, KDR, KIT, MET |
2.31049 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AURKB, AXL, DNMT1, DYRK1A, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, XDH |
2.23986 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.23986 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.16066 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
2.1562 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA4, CA7, CA9, DNMT1, MMP1, MMP2, MMP9 |
2.10351 |